|
**Overview**: Thyroid Comprehensive Panel**Introduction**: The Thyroid Comprehensive Panel is a diagnostic tool designed for thyroid function assessment using serum samples. In India, thyroid disorders affect ~42 million people (hypothyroidism ~10-15 percent in women, subclinical ~20-30 percent, higher in iodine-deficient rural/low-SES areas and post-pregnancy), contributing to fatigue, infertility, obesity, and congenital hypothyroidism if undetected in pregnancy. High morbidity from under-testing leading to delayed levothyroxine replacement, causing growth retardation in children or cardiovascular risks in adults. Per endocrinology practices aligned with ICMR, Endocrine Society of India, and National Iodine Deficiency Disorders Control Programme guidelines, the test employs immunoassay for T3, T4, TSH, anti-TPO, and anti-Tg over 1â€"2 days with high accuracy, valuable for diagnosing autoimmune thyroiditis (elevated anti-TPO/anti-Tg) and monitoring replacement. This diagnostic falls under endocrine screening and targets patients with fatigue, weight gain, goiter, infertility, or pregnancy, addressing accurate detection to guide levothyroxine dosing and autoimmune management. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling comprehensive thyroid profiling and reducing metabolic/reproductive burden. Its serum-based approach ensures reliable hormone/autoantibody assessment.**Other Names**: Thyroid Comp Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry/endocrinology, compliant with 2025 standards.**Historical Milestone**: TSH + free T4 + autoantibodies standard in thyroid workup; in India, core of iodine program monitoring.**Purpose**: The test assesses 5 parameters including T3, T4, TSH to guide thyroid disorder screening, detect hypo/hyperthyroidism/autoimmunity, inform replacement.**Test Parameters**: 1. T3, 2. T4, 3. TSH, 4. Anti-TPO, 5. Anti-Tg.**Pretest Condition**: Fasting 10-12 hours recommended; patients should have thyroid symptoms.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve hormone integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on fatigue, weight changes, goiter.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected thyroid disorder including infertility/cardiac issues, benefits of screening, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1â€"2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: High TSH + low T4 indicates hypothyroidism; elevated anti-TPO/anti-Tg confirms autoimmune etiology, necessitating specialist input.**Specialist Consultation**: Endocrinologists should be consulted for management.**Additional Supporting Tests**: Thyroid ultrasound, anti-TSH receptor for confirmation.**Test Limitations**: Pregnancy/trimester-specific ranges; comprehensive approach required.**References**: Indian Journal of Endocrinology 2024, Thyroid Studies India 2023. |
